Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the ...

The U.S. Army Corps of Engineers is working to improve four of its locks and dams through a Consolidated Lock Closure, ...

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...

Continuous monitoring provides utilities with an early warning system to detect potential faults or issues before a serious ...

There are almost no words to describe the massive path of destruction left by Hurricanes Helene and Milton in Florida and the ...

This guide serves as a foundational resource for developing fintech software, which is central to the innovation in financial ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

A deadline looms in negotiations between Norfolk Southern and the Shenandoah Valley Battlefields Foundation for the purchase ...

Florida condo sales are slowing and prices are dropping as a buyer's market emerges following new Surfside safety inspection law.

This week’s recap highlights several significant FDA developments. We also cover ongoing successes of pembrolizumab with chemotherapy in NSCLC.

"Instead of looking at AD just through the usual lens of plaques and tangles, we focused on how specific cell types were changed in each phase," study author Dr. Kyle Travaglini, Ph.D., a ...